Greg Keenan, Chief Medical Officer at Aurinia Pharmaceuticals Inc. (AUPH), sold 12,239 shares at $8.00 ($98K) on 2025-03-03, disclosed to the SEC on 2025-03-04.
Open-market sale of $98k AUPH by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |